Skip to content
10-K

Annual Report

ENANTA PHARMACEUTICALS INC ENTA

0001193125-25-288121

← back to feed
Filed
Nov 19, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Nov 4, 2025 28.86M sh
Shares Diluted FY 2025 · Sep 30, 2025 21.34K sh
Shares Diluted FY 2025 · Sep 30, 2024 21.16K sh
Shares Diluted FY 2025 · Sep 30, 2023 20.97K sh
Capex FY 2025 · Sep 30, 2025 $12.9M
Capex FY 2025 · Sep 30, 2024 $17.95M
Capex FY 2025 · Sep 30, 2023 $9.06M
Operating Cash Flow FY 2025 · Sep 30, 2025 −$19.27M
Operating Cash Flow FY 2025 · Sep 30, 2024 −$78.76M
Operating Cash Flow FY 2025 · Sep 30, 2023 −$103.15M
Cash And Equivalents FY 2025 · Sep 30, 2025 $32.3M
Cash And Equivalents FY 2025 · Sep 30, 2024 $37.23M
Stockholders Equity FY 2025 · Sep 30, 2025 $64.72M
Stockholders Equity FY 2025 · Sep 30, 2024 $128.81M
Stockholders Equity FY 2025 · Sep 30, 2023 $216.74M
Stockholders Equity FY 2025 · Sep 30, 2022 $321.33M
Current Liabilities FY 2025 · Sep 30, 2025 $48.56M
Current Liabilities FY 2025 · Sep 30, 2024 $57.54M
Total Liabilities FY 2025 · Sep 30, 2025 $216.02M
Total Liabilities FY 2025 · Sep 30, 2024 $247.84M
Current Assets FY 2025 · Sep 30, 2025 $204.34M
Current Assets FY 2025 · Sep 30, 2024 $299.85M
Total Assets FY 2025 · Sep 30, 2025 $280.73M
Total Assets FY 2025 · Sep 30, 2024 $376.65M
Eps Diluted FY 2025 · Sep 30, 2025 −$3.84
Eps Diluted FY 2025 · Sep 30, 2024 −$5.48
Eps Diluted FY 2025 · Sep 30, 2023 −$6.38
Eps Basic FY 2025 · Sep 30, 2025 −$3.84
Eps Basic FY 2025 · Sep 30, 2024 −$5.48
Eps Basic FY 2025 · Sep 30, 2023 −$6.38
Sga Expense FY 2025 · Sep 30, 2025 $43.93M
Sga Expense FY 2025 · Sep 30, 2024 $57.85M
Sga Expense FY 2025 · Sep 30, 2023 $52.89M
Rd Expense FY 2025 · Sep 30, 2025 $106.74M
Rd Expense FY 2025 · Sep 30, 2024 $131.48M
Rd Expense FY 2025 · Sep 30, 2023 $163.52M
Net Income FY 2025 · Sep 30, 2025 −$81.89M
Net Income FY 2025 · Sep 30, 2024 −$116.05M
Net Income FY 2025 · Sep 30, 2023 −$133.82M
Operating Income FY 2025 · Sep 30, 2025 −$85.35M
Operating Income FY 2025 · Sep 30, 2024 −$121.69M
Operating Income FY 2025 · Sep 30, 2023 −$137.21M
Revenue FY 2025 · Sep 30, 2025 $65.32M
Revenue FY 2025 · Sep 30, 2024 $67.64M
Revenue FY 2025 · Sep 30, 2023 $79.2M